SCHEMBL3883583

SCHEMBL3883583

Nc1cc(CCC(=O)O)cc(-c2ccc3[nH]ccc3c2)c1OC1Cc2ccccc2C1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ENPP2 Q13822 1/20 0.40
FFAR4 Q5NUL3 4/20 0.39
NPC1 O15118 1/20 0.37
CTNNB1 P35222 1/20 0.36
WNT3A P56704 1/20 0.36
ATR Q13535 1/20 0.36
LTB4R Q15722 1/20 0.36
PTGS2 P35354 1/20 0.35
VCP P55072 2/20 0.35
THRA P10827 1/20 0.35
THRB P10828 1/20 0.35
FFAR1 O14842 1/20 0.34
AR P10275 1/20 0.34
ACHE P22303 1/20 0.34
HTR4 Q13639 1/20 0.34
SIGMAR1 Q99720 1/20 0.34
EPHX1 P07099 1/20 0.34
CYP2D6 P10635 1/20 0.34
EPHX2 P34913 1/20 0.34
SLC6A2 P23975 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3882472 0.90 ENPP2 (0.38) ENPP2CTNNB1WNT3AATRPTGS2
SCHEMBL3680532 0.88 THRA (0.48) ENPP2FFAR4PTGS2THRATHRB
SCHEMBL3887598 0.88 FFAR4 (0.47) FFAR4THRATHRBFFAR1
SCHEMBL3883630 0.87 THRA (0.50) ENPP2FFAR4PTGS2THRATHRB
SCHEMBL3884996 0.86 ENPP2 (0.38) ENPP2FFAR4NPC1CTNNB1WNT3A
SCHEMBL3884991 0.86 ENPP2 (0.38) ENPP2FFAR4NPC1CTNNB1WNT3A
SCHEMBL3882470 0.86 PTGS2 (0.41) ENPP2NPC1ATRPTGS2VCP
SCHEMBL923645 0.85 TRPA1 (0.41) FFAR4CTNNB1WNT3AATR
SCHEMBL28752889 0.82 FFAR4 (0.44) ENPP2FFAR4NPC1CTNNB1WNT3A
SCHEMBL3887162 0.81 FFAR4 (0.39) FFAR4AR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1477472-B1 SUBSTITUTED PHENYLALKANOIC ACID DERIVATIVE AND USE THEREOF ASAHI KASEI PHARMA CORP (JP) 2009-01-14 EP claimed
US-6867320-B2 Substituted phenylalkanoic acid derivatives and use thereof ASAHI KASEI PHARMA CORPORATION (JP) 2005-03-15 US claimed
EP-1477472-A1 SUBSTITUTED PHENYLALKANOIC ACID DERIVATIVE AND USE THEREOF Asahi Kasei Pharma Corporation (JP) 2004-11-17 EP claimed
US-20040044258-A1 Substituted phenylalkanoic acid derivatives and use thereof ASAHI KASEI PHARMA CORPORATION (JP) 2004-03-04 US claimed
EP-1477472-B1 SUBSTITUTED PHENYLALKANOIC ACID DERIVATIVE AND USE THEREOF ASAHI KASEI PHARMA CORP (JP) 2009-01-14 EP disclosed
US-6867320-B2 Substituted phenylalkanoic acid derivatives and use thereof ASAHI KASEI PHARMA CORPORATION (JP) 2005-03-15 US disclosed
EP-1477472-A1 SUBSTITUTED PHENYLALKANOIC ACID DERIVATIVE AND USE THEREOF Asahi Kasei Pharma Corporation (JP) 2004-11-17 EP disclosed
US-20040044258-A1 Substituted phenylalkanoic acid derivatives and use thereof ASAHI KASEI PHARMA CORPORATION (JP) 2004-03-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040044258-A1 Substituted phenylalkanoic acid derivatives and use thereof PTGER1, CYSLTR1, PTGS1 ENPP2 333/4885FFAR4 115/4885NPC1 84/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.